rs148510648
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004696.3(SLC16A4):c.662A>C(p.Glu221Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004696.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251400Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135874
GnomAD4 exome AF: 0.000147 AC: 215AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.000153 AC XY: 111AN XY: 727242
GnomAD4 genome AF: 0.000131 AC: 20AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.662A>C (p.E221A) alteration is located in exon 6 (coding exon 5) of the SLC16A4 gene. This alteration results from a A to C substitution at nucleotide position 662, causing the glutamic acid (E) at amino acid position 221 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at